The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies: comment
- PMID: 32564289
- PMCID: PMC7305057
- DOI: 10.1007/s11739-020-02406-z
The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies: comment
Conflict of interest statement
The author declares that this “Letter to the editor” article was written in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment in
-
The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based antihypertensive therapies-reply.Intern Emerg Med. 2020 Nov;15(8):1583-1584. doi: 10.1007/s11739-020-02436-7. Epub 2020 Jul 14. Intern Emerg Med. 2020. PMID: 32666177 Free PMC article. No abstract available.
Comment on
-
The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.Intern Emerg Med. 2020 Aug;15(5):759-766. doi: 10.1007/s11739-020-02364-6. Epub 2020 May 19. Intern Emerg Med. 2020. PMID: 32430651 Free PMC article.
References
-
- Albini A, Di Guardo G, McClain Noonan D, Lombardo M. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies. Intern Emerg Med. 2020;19:1–8. doi: 10.1007/s11739-020-02364-6. - DOI - PMC - PubMed
-
- Stopsack KH, Mucci LA, Antonarakis ES, Nelson PS, Kantoff PW. TMPRSS2 and COVID-19: serendipity or opportunity for intervention? Cancer Discov. 2020 doi: 10.1158/2159-8290.CD-20-0451. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
